- Molecular composition of Fiasp®
- Formulation details
- Onset of appearance study results
- Dose timing
See how Fiasp® works in the body to help regulate insulin for patients with type 1 and type 2 diabetes (patient-friendly language).
Patients can learn more about Fiasp® by viewing this video on MyFiasp.com.
Fiasp® (insulin aspart injection) 100 U/mL is a rapid-acting insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
Please click here for Prescribing Information.
NovoLog® (insulin aspart injection) 100 U/mL is an insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.
NovoLog® continuous subcutaneous infusion route (insulin pump): Do not mix NovoLog® with any other insulin or diluent.
Please click here for Prescribing Information.